Botulinum toxin for diabetic neuropathic pain: a randomized double-blind crossover trial. - Wikidata - awgldk - TriplyDB

Botulinum toxin for diabetic neuropathic pain: a randomized double-blind crossover trial.

Botulinum toxin for diabetic neuropathic pain: a randomized double-blind crossover trial.

http://www.wikidata.org/entity/Q46107474

about

Botulinum toxins for the prevention of migraine in adults Neuromodulators for pain management in rheumatoid arthritis Neuromodulators for pain management in rheumatoid arthritis Recommendations for the pharmacological management of neuropathic pain: an overview and literature update Spotlight on botulinum toxin and its potential in the treatment of stroke-related spasticity Current status and future directions of botulinum neurotoxins for targeting pain processing Botulinum Toxin for Neuropathic Pain: A Review of the Literature The Role of Botulinum Toxin Type A in the Clinical Management of Refractory Anterior Knee Pain The Rehabilitation of Oncological Patients Presenting Neuropathies Botulinum Toxin Type A for the Treatment of Neuropathic Pain in Neuro-Rehabilitation The management of diabetic neuropathy in CKD.Treating Diabetic Neuropathy: Present Strategies and Emerging Solutions.Therapeutic effect of Botulinum toxin-A in 88 patients with trigeminal neuralgia with 14-month follow-up.EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision.Blockade of glutamate release by botulinum neurotoxin type A in humans: a dermal microdialysis study.Diabetic neuropathy: clinical manifestations and current treatments.Therapeutic use of botulinum toxin in migraine: mechanisms of action.Treatment of painful diabetic neuropathy Intraarticular botulinum toxin A for refractory painful total knee arthroplasty: a randomized controlled trial.Burning through the pain: treatments for diabetic neuropathy.Botulinum toxin therapy for osteoarticular pain: an evidence-based review Pharmacological management of chronic neuropathic pain: revised consensus statement from the Canadian Pain Society.Botulinum Toxin-A for Painful Diabetic Neuropathy: A Meta-Analysis.Botulinum toxin in migraine: Role of transport in trigemino-somatic and trigemino-vascular afferents.A robust approach for identifying differentially abundant features in metagenomic samples Efficient assessment of efficacy in post-traumatic peripheral neuropathic pain patients: pregabalin in a randomized, placebo-controlled, crossover study Clinical uses of botulinum neurotoxins: current indications, limitations and future developments A review of thoracic outlet syndrome and the possible role of botulinum toxin in the treatment of this syndrome Ultrasound-Guided Nerve Block with Botulinum Toxin Type A for Intractable Neuropathic Pain.Botulinum toxin type A for neuropathic pain in patients with spinal cord injury.Treatment of Morton neuroma with botulinum toxin A: a pilot study.Use of botulinum toxin in musculoskeletal pain.Botulinum toxin injection in neurogenic thoracic outlet syndrome: results and experience using a ultrasound-guided approach.Effects of enzymatically inactive recombinant botulinum neurotoxin type A at the mouse neuromuscular junctions.The effects of intradermal botulinum toxin type a injections on pain symptoms of patients with diabetic neuropathy.Pharmacological treatment of diabetic neuropathic pain.Treatment of refractory pain with botulinum toxins--an evidence-based review.Diabetic neuropathy and oxidative stress: therapeutic perspectives.OnabotulinumtoxinA for the treatment of headache.More than at the neuromuscular synapse: actions of botulinum neurotoxin A in the central nervous system.

P2860

Q24186932-CC55C68C-44DD-42BA-9FC2-E3107100E3D9 Q24203885-317745FF-3470-48C7-A018-788AF5557E6C Q24235149-F128EBDC-BCD0-452E-854D-BA8C45C947E5 Q24616897-A0A0449C-157A-4AC6-B308-CA64A88FE70B Q26750450-736C3416-4AE5-4597-82E3-BDAE9488B4BB Q26778129-0E79491B-1F5D-4FFA-9D9B-F0610884310C Q26796604-B9996471-61D4-4D9A-A548-D4739ECAE34E Q26797317-7B462327-1929-488C-AC31-6F1945135361 Q27024318-6D4A6164-3F4A-4189-9A6B-3524C2836118 Q28088625-6D8D7B27-5404-47B9-B4E3-A21D149C2E71 Q33554396-09EBBF15-66E9-40F3-9E65-90F72198C54E Q33583006-6A817988-11CE-4E7B-90BF-303107319D11 Q33828749-E3B98DA5-9049-4A02-A9FB-EA1563980A76 Q34110857-886AC9F0-671F-40B9-B0AC-3A5E20C6C785 Q34154494-A13DD30E-7802-42F5-B507-90BA1EB861D4 Q34275990-826B8199-08A1-49B0-881D-44884E6B1281 Q34419654-829E2FF0-2BE0-44AF-92A8-1E4A9B1A3950 Q34456265-07787BB5-DF4E-4481-895E-E372375C110B Q34479556-AE63A1F5-582C-4306-AFA2-0793BB8BEE3E Q34485306-6C70015F-033A-4148-8E89-1BE6CCA67113 Q34554147-979B776B-C6EE-44ED-B686-2539667874CB Q34756198-0D32AE0C-74B2-4A52-8C48-1CB7328A2159 Q35584564-0EC01399-FEEF-483A-A7B0-809566D23625 Q35691221-667AC17B-72B0-4215-A9DB-595CD48DDB62 Q35829702-166D615C-241A-417E-9DB4-35B4B08633E8 Q36145852-26315170-B251-4F79-B225-5FAE742608D1 Q36395728-506C5CBF-5915-4686-AB61-1D8DA402F58E Q36432805-5C74C102-465B-4870-9388-E8969FA53FDD Q36507197-AD41C2D0-F7D7-49A5-8253-ACFACD15EDD2 Q36780108-F62718EE-9929-4F0C-9CAC-4CF3B7E8AC47 Q36952082-50281917-827A-4679-82E7-E73FE7DCCB58 Q37671002-BD826C97-9C2D-4297-9C29-B36EF6D83EB9 Q37698986-DC66C0FE-629C-4C8D-8C7B-0BB5C1A70DCF Q37700722-574D1572-7C29-4386-8618-17581AA25064 Q37723197-E40D3763-E5EC-43CF-AE15-E681773AC239 Q37858519-95994A55-9EDC-4121-9047-46B6F28EDA69 Q37940623-24B555A5-CD8D-4092-BB00-60F8C9155B24 Q38112117-69EABD9B-8E8E-4F6D-ABFA-73F3C3D62AE6 Q38136258-4D8091B5-9B1D-4414-913A-08EDBB6B47AA Q38191755-3F8C4894-C273-4B63-BD3F-C99F4BC7945F

P2860

Botulinum toxin for diabetic neuropathic pain: a randomized double-blind crossover trial.

http://www.wikidata.org/entity/Q46107474

description

2009 nî lūn-bûn

@nan

2009年の論文

@ja

2009年学术文章

@wuu

2009年学术文章

@zh

2009年学术文章

@zh-cn

2009年学术文章

@zh-hans

2009年学术文章

@zh-my

2009年学术文章

@zh-sg

2009年學術文章

@yue

2009年學術文章

@zh-hant

name

Botulinum toxin for diabetic neuropathic pain: a randomized double-blind crossover trial.

@en

Botulinum toxin for diabetic neuropathic pain: a randomized double-blind crossover trial.

@nl

type

label

Botulinum toxin for diabetic neuropathic pain: a randomized double-blind crossover trial.

@en

Botulinum toxin for diabetic neuropathic pain: a randomized double-blind crossover trial.

@nl

prefLabel

Botulinum toxin for diabetic neuropathic pain: a randomized double-blind crossover trial.

@en

Botulinum toxin for diabetic neuropathic pain: a randomized double-blind crossover trial.

@nl

P1433

Q46107474-B78A1C74-7127-48CD-8C8A-17619481D2A5

P1476

Q46107474-E46CBE0B-99E0-466F-8F17-ABD7C240FE61

P2093

Q46107474-36A98EAC-565E-4D3D-AFFC-FCAD9DA9EB3A

Q46107474-3CD00C06-A145-4B28-92BF-6926F89F9A1B

Q46107474-78180615-4870-4386-9B8B-F81A69FDBEF7

Q46107474-95817D0C-B394-49A2-B7C4-79117ED83069

Q46107474-C9EE5DD3-180D-4821-967D-0E5E1B634F86

Q46107474-F9FFD81D-B217-45B9-B28F-72FDA4B0875B

Q46107474-FA21B8BF-99FF-4BC0-B10D-64ED0E3B14A4

P304

Q46107474-1434B2DA-E804-4150-BAC3-304BEA541BD9

P31

Q46107474-5C91DE0E-2253-456B-8C14-07A1FFD0C1F9

P356

Q46107474-70A5FE69-D751-4FA4-86A3-1962AA9D93B9

P407

Q46107474-AA8D5F8B-A147-44D6-93B2-845D6BB21DD7

P433

Q46107474-A5BB643F-3DD8-4ECF-B027-A06472A52478

P478

Q46107474-5F6DB91B-16FB-404E-84FC-672B23DB2F98

P577

Q46107474-45E72307-2900-468F-99EE-FBE6B333A076

P5875

Q46107474-F1951267-F3D5-4719-930E-86B4B8DC158B

P698

Q46107474-A01DA87C-1C3B-4F90-8BA2-CD85A382D2AF

P921

Q46107474-A8B188F4-74B8-4755-963B-48C7B60E29D6

P356

01.WNL.0000345968.05959.CF

P1433

P1476

Botulinum toxin for diabetic neuropathic pain: a randomized double-blind crossover trial.

@en

P2093

C J Hu

http://www.w3.org/2001/XMLSchema#string

H H Chang

http://www.w3.org/2001/XMLSchema#string

I J Tseng

http://www.w3.org/2001/XMLSchema#string

J J Sheu

http://www.w3.org/2001/XMLSchema#string

J M Yu

http://www.w3.org/2001/XMLSchema#string

R Y Yuan

http://www.w3.org/2001/XMLSchema#string

W T Chen

http://www.w3.org/2001/XMLSchema#string

P304

1473-1478

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1212/01.WNL.0000345968.05959.CF

http://www.w3.org/2001/XMLSchema#string

P407

P433

17

http://www.w3.org/2001/XMLSchema#string

P478

72

http://www.w3.org/2001/XMLSchema#string

P577

2009-02-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

24043674

http://www.w3.org/2001/XMLSchema#string

P698

19246421

http://www.w3.org/2001/XMLSchema#string

P921

neuropathic pain